Compare SUNS & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUNS | INO |
|---|---|---|
| Founded | 2023 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.3M | 114.0M |
| IPO Year | N/A | 1999 |
| Metric | SUNS | INO |
|---|---|---|
| Price | $7.99 | $1.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $8.75 | $6.75 |
| AVG Volume (30 Days) | 91.1K | ★ 624.8K |
| Earning Date | 03-12-2026 | 03-12-2026 |
| Dividend Yield | ★ 14.87% | N/A |
| EPS Growth | N/A | ★ 54.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,220,086.00 |
| Revenue This Year | $91.00 | $24,407.60 |
| Revenue Next Year | $20.79 | $331.40 |
| P/E Ratio | $8.84 | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $7.80 | $1.30 |
| 52 Week High | $11.78 | $2.86 |
| Indicator | SUNS | INO |
|---|---|---|
| Relative Strength Index (RSI) | 28.53 | 44.05 |
| Support Level | N/A | $1.48 |
| Resistance Level | $9.69 | $1.78 |
| Average True Range (ATR) | 0.27 | 0.08 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 4.58 | 35.19 |
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.